20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Liquid pharmaceutical composition
#2402Botulinum toxin and colloidal silver particles
#2403Formulations of diluted amino acid segments and methods for making same
#2404STABLE PHARMACEUTICAL COMPOSITIONS
#2405Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#2406Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#2407PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII
#2408Lyophilized formulation of HGF
#2409Diketopiperazine microparticles with defined specific surface areas
#2410Stable formulations for lyophilizing therapeutic particles
#2411Lyophilized compositions comprising albumin-rankl or albumin-GD2 paclitaxel nanoparticle complexes
#2412Methods of using albumin-antibody nanoparticle complex compositions for treating cancer
#2413Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating cancer
#2414Lyophilized compositions comprising albumin-antibody paclitaxel nanoparticle complexes
#2415Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same
#2416Lyophilized compositions comprosing albumin-EGFR paclitaxel nanoparticle complexes
#2417Albumin-CTLA-4 paclitaxel nanopartilce complex compositions and methods of making and using the same
#2418Methods of making lyophilized compositions comprising albumin-VEGF paclitaxel nanoparticle complexes
#2419Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#2420Lyophilized factor IX formulations
#2421Quick dissolving diphenhydramine oral dosage form
#2422Polycarbonate containing compounds and methods related thereto
#2423Modified starch material of biocompatible hemostasis
#2424INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ARGINYL-TRNA SYNTHETASES
#2425Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
#2426ENHANCED DELIVERY OF IMMUNOSUPPRESSIVE DRUG COMPOSITIONS FOR PULMONARY DELIVERY
#2427HPV vaccine formulations comprising aluminum adjuvant and methods of producing same
#2428High purity oritavancin and method of producing same
#2429Pharmaceutical composition containing docetaxel
#2430Method of producing lipid nanoparticles for drug delivery
#2431Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
#2432Method for protecting kidney function
#2433Compositions comprising bacterial strains
#2434Compositions comprising bacterial strains
#2435Compositions comprising bacterial strains
#2436Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
#2437Stable liquid formulations of cyclophosphamide and processes to prepare the same
#2438COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#2439Treatment using dantrolene
#2440Nanoparticles, method of preparing the same and their use
#2441Tannin-chitosan composites
#2442Dry platelet composition
#2443Modified starch material of biocompatible hemostasis
#2444ALLISARTAN ISOPROXIL SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION
#2445Stabilised Solid Compositions of Factor VII Polypeptides
#2446Method of Administering Porcine B-Domainless fVIII
#2447Chloride salt of TAT-NR2B9c
#2448THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#2449Solid oral dosage form of lipophilic compounds
#2450Synthetic derivatives of MPL and uses thereof
#2451Lyophilized pharmaceutical composition of Fc-peptide fusion protein
#2452Formulations of hepalatide
#2453Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#2454Durable preparation of an injectable of melatonin exhibiting long-term stability
#2455Lyophilized formulation of TAT-NR2B9C with acetylation scavenger
#2456Pharmaceutical formulation containing gelling agent
#2457Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof
#2458Liquid pharmaceutical composition of adalimumab
#2459Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
#2460BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME
#2461Carrier-antibody compositions and methods of making and using the same
#2462AMNIOTIC FLUID TOPICAL FORMULATION
#2463Reduction of Lipoma Tissue
#2464Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof
#2465Methods for freeze-drying and rehydrating biologics
#2466COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#2467Factor VIII formulations
#2468Anti-vascular disease and antitumor pharmaceutical composition and use thereof
#2469IRINOTECAN HYDROCHLORIDE COMPOSITE PHOSPHOLIPID COMPOSITION, PREPARATION METHOD AND USE THEREOF
#2470Compositions and methods for atmospheric spray freeze drying
#2471Site-specific conjugation of linker drugs to antibodies and resulting ADCs
#2472Stabilization of factor VIII without calcium as an excipient
#2473Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#2474Solid forms of bendamustine hydrochloride
#2475Dihydropyrazoles
#2476Carrier-antibody compositions and methods of making and using the same
#2477Methods for fabrication of epinephrine bitartrate nanoparticles and epinephrine bitartrate nanoparticles fabricated thereby
#2478Composition of nanoformulated lycopene and method of using the composition
#2479VLP stabilized vaccine compositions
#2480Process for preparing an attenuated tetravalent dengue vaccine
#2481Stable Factor VIII formulations with low sugar-glycine
#2482Proliposomal testosterone formulations
#2483Vaccine delivery systems using yeast cell wall particles
#2484DRUG-DELIVERING COMPOSITE STRUCTURES
#2485Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair
#2486Formulation of human antibodies for treating TNF-alpha associated disorders
#2487Dry growth hormone composition transiently linked to a polymer carrier
#2488Risperidone sustained release microsphere composition
#2489Microcapsule formulation and method for producing the same
#2490Hydrogels of methacrylic hyaluronic acid derivatives for oral enzyme therapy in celiac disease
#2491Pharmaceutical formulations
#2492Lyophilized preparation of cytotoxic dipeptides
#2493Agent for capturing tumor cells and methods of use thereof
#2494Stable formulations for parenteral injection of peptide drugs
#2495Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2496Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
#2497Bioerodible silicon-based compositions for delivery of therapeutic agents
#2498Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections
#2499Use of multi-arm polyethylene glycol modifier and application of multi-arm polyethylene glycol modifier in L-asparaginasum modification
#2500Methods of treatment using alpha-1-antitrypsin compositions
#2501Long lasting effect of new botulinum toxin formulations
#2502CNS delivery of therapeutic agents
#2503Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract
#2504Lyophilized lentiviral vector particles, compositions and methods
#2505Antibody drug conjugates
#2506Dehydrated hydrogel inclusion complex
#2507Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose
#2508METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
#2509Stable protein formulations comprising a molar excess of sorbitol
#2510STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
#2511Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#2512for the treatment of mastitis
#2513Compositions for introducing RNA into cells
#2514Carrier-antibody compositions and methods of making and using the same
#2515Carrier-antibody compositions and methods of making and using the same
#2516Vaccine compositions
#2517Compositions and methods for nanoparticle lyophile forms
#2518DUOCARMYCIN ADCS SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITY
#2519VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES
#2520Formula of neuregulin preparation
#2521COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
#2522Methods of treating ulcerative colitis
#2523Polypeptides
#2524Stabilizing composition for biological materials
#2525Therapeutic agent for disc herniation
#2526Lyophilized pharmaceutical compositions
#2527Oral delivery system for hemoglobin based oxygen carriers
#2528Composition comprising a polymer and a bioactive agent and method of preparing thereof
#2529METHODS FOR PRODUCING HIGH CONCENTRATION LYOPHILIZED PHARMACEUTICAL FORMULATIONS
#2530Stabilized liquid and lyophilized ADAMTS13 formulations
#2531Probiotic recolonisation therapy
#2532Probiotic recolonisation therapy
#2533Probiotic recolonisation therapy
#2534Macrolide particulates, methods for preparation, and medical devices associated therewith
#2535Peptide/particle delivery systems
#2536ANTIBODY FORMULATION
#2537DRUG CONJUGATE COMPOSITION
#2538REDUCED-VISCOSITY CONCENTRATED PROTEIN FORMULATIONS
#2539Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers
#2540ROMIDEPSIN FORMULATIONS AND USES THEREOF
#2541Preparation of acetate salt compositions of pharmaceutical agents
#2542Microbiota restoration therapy (MRT) compositions and methods of manufacture
#2543Methods for the preparation of liposomes
#2544Methods for the production of biopolymers with defined average molecular weight
#2545CARDIAC FIBROBLAST-DERIVED EXTRACELLULAR MATRIX AND INJECTABLE FORMULATIONS THEREOF FOR TREATMENT OF ISCHEMIC DISEASE OR INJURY
#2546EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#2547SYRINGES AND METHODS OF USING THEM TO TREAT OVERACTIVE BLADDER
#2548MODIFIED PARAMAGNETIC NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTICS AND METHODS THEREOF
#2549Drug formulations
#2550Endoxifen compositions and methods
#2551Methods of treating ulcerative colitis
#2552Carrier-antibody compositions and methods of making and using the same
#2553Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
#2554Methods of treating, reducing the incidence of, and/or preventing ischemic events
#2555Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
#2556Carrier-antibody compositions and methods of making and using the same
#2557Drug loaded polymeric nanoparticles and methods of making and using same
#2558Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders
#2559Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
#2560Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#2561Process for reconstitution of a solid form of a pharmaceutical composition
#2562Hypericin albumin nanoparticle-serum antibody complex and preperation method and application thereof
#2563Temperature stable vaccine formulations
#2564LYOPHILIZED MESNA COMPOSITIONS
#2565Single vial vaccine formulations
#2566Remote loading of sparingly water-soluble drugs into liposomes
#2567Allergen dosage form
#2568Pharmaceutical compositions containing toxoids A and B
#2569Antibiotic formulations, unit doses, kits, and methods
#2570Pharmaceutical composition not containing antioxidant and preparation method therefor
#2571Freeze dried drug nanosuspensions
#2572Pharmaceutical composition containing palonosetron
#2573Composition comprising tetracyclic compound
#2574Compositions For Treating Acute, Post-Operative, Or Chronic Pain And Methods of Using The Same
#2575Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#2576Caspofungin Acetate Formulations
#2577Multi-epitope TARP peptide vaccine and uses thereof
#2578Pharmaceutical compositions of tenecteplase
#2579Pharmaceutical compositions comprising pemetrexed and tromethamine
#2580Antibody formulations and methods for treating AL amyloidosis
#2581Microparticles and nanoparticles having negative surface charges
#2582Bendamustine solid dispersions and continuous infusion
#2583Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#2584PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IRON DEFICIENCY, COMPRISING IRON OXIDE NANOPARTICLES
#2585Method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions
#2586EPHEDRA ALATA EXTRACTS AND METHODS OF USE THEREOF
#2587Formulation and process for modulating wound healing
#2588Composition for oral delivery of bioactive agents
#2589RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS THEREOF
#2590Method of manufacturing and purifying prothrombin complex concentrate from Fraction III for intravenous injection and a method of curing and preventing Hemophilia A with inhibitors or Hemophilia B in patients infected with HIV-1 and HIV-2
#2591METHOD OF MANUFACTURING AN AFOD INTRAVENOUS INJECTION FROM FRACTION IV TO PREVENT AND KILL HIV-1 AND HIV-2
#2592SUBSTITUTED-IMIDAZOPYRIDAZINES
#2593Lyophilized anti-tissue factor antibody-drug conjugates
#2594Storage stable lyophilized tripeptide formulations
#2595CVS transplantation for treatment of bacterial vaginosis
#2596Factor VII composition
#2597PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#2598Compositions and methods for treating and preventing tissue injury and disease
#2599Lyophilized preparations of melphalan flufenamide
#2600Recombinant glycoproteins and uses thereof
#2601Anti-TNF antibodies, compositions, methods and uses
#2602Heteroaryl compounds as BTK inhibitors and uses thereof
#2603Low molecular weight silk compositions and stabilizing silk compositions
#2604Formulations of single domain antigen binding molecules
#2605Pantoprazole Sodium Composition Lyophilized Powder for Injection
#2606Stabilizing agent for pharmaceutical proteins
#2607Albumin-free botulinum toxin formulations
#2608Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#2609METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#2610Thermostable respiratory synctial virus (RSV) vaccine compositions
#2611Human Papilloma virus therapeutic vaccine
#2612Composition for treating and preventing benign prostatic hyperplasia
#2613Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis
#2614COMPOSITIONS AND METHODS FOR TREATING PSORIATIC ARTHRITIS
#2615VEGF antagonist formulations suitable for intravitreal administration
#2616VEGF specific fusion protein antagonist formulations
#2617Nucleic acid-lipopolymer compositions
#2618RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
#2619Compositions and methods comprising a defined microbiome and methods of use thereof
#2620Polysialic acid-polycaprolactone micelles for drug delivery
#2621Process for stabilizing an adjuvant containing vaccine composition
#2622BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#2623High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#2624Mixed micelles
#2625LIPOSOME ENCAPSULATED AFFINITY DRUG
#2626Method of obtaining thermostable dried vaccine formulations
#2627Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#2628INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS
#2629FREEZE-DRIED FORMULATIONS OF FGF-18
#2630STABLE SOLID UNITS AND METHODS OF MAKING THE SAME
#2631Compositions and method for anti-sickling of red blood cells in sickle cell disease
#2632Recombinant clusterin and use thereof in the treatment and prevention of disease
#2633Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#2634Liquid formulation of long-acting human growth hormone immunoglobulin conjugate
#2635Pharmaceutical composition for preventing or treating thyroid diseases, comprising extract from L. var. edulis fruits as active ingredient
#2636VEGF antagonist formulations suitable for intravitreal administration
#2637Compositions and methods for stabilizing protein-containing formulations
#2638Trans carotenoids, their synthesis, formulation and uses
#2639Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
#2640SOLID FORMULATIONS OF LIQUID BIOLOGICALLY ACTIVE AGENTS
#2641Ceftolozane-tazobactam pharmaceutical compositions
#2642Chlorogenic acid powder-injection and preparation method thereof
#2643Carrier-antibody compositions and methods of making and using the same
#2644Carrier-antibody compositions and methods of making and using the same
#2645Carrier-antibody compositions and methods of making and using the same
#2646Stable VEGF antagonist formulations
#2647Crystalline forms of a biphenyl compound
#2648Subcutaneous anti-HER2 antibody formulations and uses thereof
#2649NON-CHEMOTHERAPEUTIC ANTIBIOTIC TREATMENT FOR INFECTIONS IN CATTLE
#2650Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment
#2651Solid forms of bendamustine hydrochloride
#2652NOVEL RECONSTITUTION ASSEMBLY
#2653Method for the treatment of nanohydrogels
#2654METHODS AND FORMULATIONS WHICH ALLOW THE MODULATION OF IMMUNE RESPONSES RELATED TO THE ADMINISTRATION OF A BIOPHARMACEUTICAL DRUG
#2655Probiotic recolonisation therapy
#2656Probiotic recolonisation therapy
#2657Probiotic recolonisation therapy
#2658Methods for treatment of diseases
#2659Freeze-dried preparation containing high-purity PTH and method for producing same
#2660Tigecycline compositions and methods of preparation
#2661Probiotic compositions containing clostridiales for inhibiting inflammation
#2662Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
#2663STABLE PHARMACEUTICAL COMPOSITIONS
#2664STABLE AND WATER SOLUBLE PHARMACEUTICAL COMPOSITIONS COMPRISING PEMETREXED
#2665Method of preparing lyophilized powder for injection comprising aloe and Panax pseudo-ginseng
#2666Lyophilized therapeutic peptibody formulations
#2667Methoxypolyethylene glycol-polylactic acid block copolymer and preparation method thereof
#2668Highly concentrated pharmaceutical formulations
#2669Carmustine pharmaceutical composition
#2670METHODS FOR TREATING EPILEPSY OR SEIZURE DISORDERS
#2671Compositions For Treating Acute, Post-Operative, or Chronic Pain and Methods of Using the Same
#2672Silica hydrogel composite
#2673Lyophilized recombinant VWF formulations
#2674Use of instant asparagus powder in food, medicine and health food
#2675Stabilized statin formulations
#2676Docetaxel nano-polymer micelle lyophilized preparation and preparation method thereof
#2677Method of preparation of compositions comprising dehydrated micro-organisms
#2678Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2679Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
#2680Composition, method, and kit for alpha-1 proteinase inhibitor
#2681Authenticated encryption support in DASH based segmented streaming media distribution
#2682Fibrin wafer/disc as a biological carrier for sustained delivery of curcumin
#2683Highly concentrated formulations of soluble Fc receptors
#2684Stable formulations of immunoglobulin single variable domains
#2685Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
#2686USE OF SEA CUCUMBER GLYCOSAMINOGLYCAN IN PREPARING MEDICINE FOR PREVENTION AND TREATMENT OF THROMBOEMBOLIC DISEASE
#2687PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS
#2688Pharmaceutical preparations
#2689NEUTRALLY-CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT RESPONSE
#2690Therapeutic composition with a botulinum neurotoxin
#2691Thrombin solution and methods of use thereof
#2692Low-molecular-weight glycosaminoglycan derivative containing terminal 2, 5-anhydrated talose or derivative thereof
#2693Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#2694Particulate pharmaceutical composition
#2695Pemetrexed Formulation
#2696Strain of and its metabolites for use in inhibiting xanthine oxidase and treating gout
#2697Stable glucagon peptide formulations
#2698Xanthine oxidase inhibitor formulations
#2699Compositions with reduced dimer formation
#2700Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof